Sunday , 30 June 2024

Tag Archives: EMEA

Registration of Drug Products in European Market and their Marketing Authorization Application

Kandula Pavani*, Yarra Sai Phanindra, Pachigolla Naga Sravani, Doonaboyina Ragava, Kavala Nageswara Rao Department of Pharmaceutical Drug Regulatory Affairs, K.G.R.L College of Pharmacy, Bhimavaram-534201, Andhra Pradesh, India ABSTRACT European Union has different types of registration procedures for different types ofdrugs following which the drug may be registered in the Entire EU i.e., Centralized Procedure.The drug may be registered in one ... Read More »

Risks and Opportunities in Development of New Drug

Talagana Praveena1*, Dr. K. Harinadha Baba2, S Sivaprasadh3 1,3Sri sivani College of Pharmacy, JNTUK, Kakinada 2Principal Sri sivani College of Pharmacy, JNTUK, Kakinada A B S T R A C T Pharmaceutical development is a costly, time exhausting and uncertain process that takes years to accomplish. In many instances, patent protection expires before a new drug is approved for marketing. ... Read More »

Scroll To Top